In prior studies, GHR has been verified to be a oncogene in some cancers, such as breast cancer (15), pancreatic ductal carcinoma (16) and melanoma (17), but the role in THCA prognosis is firstly reported. The gene discussed is GHR; the disease is breast cancer.